Apollo Hospitals Enterprise Limited has received approval from the National Stock Exchange of India (NSE) for its proposed composite scheme of arrangement. The scheme involves Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, along with their respective shareholders and creditors. The approval is subject to certain conditions and compliance with regulations.
Scheme of Arrangement Approved by NSE
Apollo Hospitals Enterprise Limited announced that it has received a crucial observation letter with ‘no objection’ from the National Stock Exchange of India Limited (NSE) regarding its proposed composite scheme of arrangement. The announcement, dated December 24, 2025, highlights a significant step forward in the company’s strategic restructuring efforts.
Details of the Scheme
The scheme involves several entities, including Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The approval is for the composite scheme of arrangement amongst these companies and their respective shareholders and creditors under Sections 230 to 232 of the Companies Act, 2013.
Conditions and Further Steps
While the NSE has granted its ‘no objection’ status, the scheme remains subject to requisite statutory and regulatory approvals. These include approvals from shareholders and creditors of the involved companies. A copy of the observation letter dated December 23, 2025, is available on the company website.
NSE Conditions
The NSE stipulated certain conditions as part of its approval. The key conditions include disclosing details of ongoing adjudication and recovery proceedings against the listed entity, ensuring compliance with SEBI circulars, and providing additional disclosures to shareholders. It also states that the proposed equity shares to be issued in terms of the ‘Scheme’ shall mandatorily be in demat form only.
Source: BSE
